id	sid	eid	entity	type
fnp-2993	1	1	covid-19	ORG
fnp-2993	1	2	2:2	CARDINAL
fnp-2993	1	3	2021	CARDINAL
fnp-2993	1	4	covid-19	ORG
fnp-2993	1	5	jerry j. lou1,2*	PERSON
fnp-2993	1	6	movassaghi1*	PERSON
fnp-2993	1	7	dominique gordy1	PERSON
fnp-2993	1	8	madeline g. olson1	PERSON
fnp-2993	1	9	s. khurana2	PERSON
fnp-2993	1	10	zesheng chen1	PERSON
fnp-2993	1	11	mari perez-rosendahl2	PERSON
fnp-2993	1	12	thammachantha3	ORG
fnp-2993	1	13	elyse j. singer4	PERSON
fnp-2993	1	14	d. magaki1	PERSON
fnp-2993	1	15	harry v. vinters1,4	PERSON
fnp-2993	2	1	william h. yong1,2 1	PERSON
fnp-2993	2	2	david geffen school	PERSON
fnp-2993	2	3	ucla, usa 2	ORG
fnp-2993	2	4	university of california irvine school of medicine, usa 3	ORG
fnp-2993	2	5	thailand 4	ORG
fnp-2993	2	6	david geffen school	PERSON
fnp-2993	2	7	ucla, usa   * authors	ORG
fnp-2993	2	8	william h. yong md ·	PERSON
fnp-2993	2	9	university of california irvine school of medicine · usa and	ORG
fnp-2993	2	10	david geffen school	PERSON
fnp-2993	2	11	ucla · usa yongwh@hs.uci.edu	ORG
fnp-2993	2	12	03 september 2020	DATE
fnp-2993	2	13	14 january 2021	DATE
fnp-2993	2	14	g lucas, jr.	PERSON
fnp-2993	3	1	18	CARDINAL
fnp-2993	3	2	covid-19	PERSON
fnp-2993	3	3	2019	DATE
fnp-2993	3	4	covid-19	ORG
fnp-2993	3	5	the early 21st century	DATE
fnp-2993	4	1	2	CARDINAL
fnp-2993	4	2	2	CARDINAL
fnp-2993	5	1	covid-19	PERSON
fnp-2993	6	1	dysgeusia	PERSON
fnp-2993	6	2	84%	PERCENT
fnp-2993	6	3	6%	PERCENT
fnp-2993	6	4	meningoencephalitis	ORG
fnp-2993	8	1	guillain-barré	PERSON
fnp-2993	8	2	covid-19	GPE
fnp-2993	9	1	184	CARDINAL
fnp-2993	9	2	42.9%	PERCENT
fnp-2993	9	3	33.3%	PERCENT
fnp-2993	9	4	37.5%	PERCENT
fnp-2993	9	5	29.9%	PERCENT
fnp-2993	9	6	27.7%	PERCENT
fnp-2993	9	7	21.2%	PERCENT
fnp-2993	9	8	15.8%	PERCENT
fnp-2993	9	9	microthrombi	GPE
fnp-2993	9	10	15.2%	PERCENT
fnp-2993	11	1	covid-19 coagulopathy	PERSON
fnp-2993	12	1	one	CARDINAL
fnp-2993	13	1	meningoencephalitis	ORG
fnp-2993	17	1	1	CARDINAL
fnp-2993	17	2	late 2019	DATE
fnp-2993	17	3	wuhan	GPE
fnp-2993	17	4	china	GPE
fnp-2993	18	1	2003	DATE
fnp-2993	19	1	the international committee of taxonomy of viruses	ORG
fnp-2993	19	2	2	CARDINAL
fnp-2993	19	3	the world health organization	ORG
fnp-2993	19	4	2019	DATE
fnp-2993	19	5	covid-19	PRODUCT
fnp-2993	19	6	the end of december 2020	DATE
fnp-2993	19	7	over 79 million	CARDINAL
fnp-2993	19	8	1.7 million	CARDINAL
fnp-2993	19	9	deaths.2	NORP
fnp-2993	21	1	covid-19	PERSON
fnp-2993	22	1	covid-19 neuropathological	ORG
fnp-2993	24	1	2	CARDINAL
fnp-2993	25	1	four	CARDINAL
fnp-2993	25	2	60	CARDINAL
fnp-2993	25	3	140	CARDINAL
fnp-2993	25	4	middle east	LOC
fnp-2993	26	1	~50	EVENT
fnp-2993	26	2	16	CARDINAL
fnp-2993	26	3	four	CARDINAL
fnp-2993	26	4	1).3,8,9	CARDINAL
fnp-2993	26	5	europe	LOC
fnp-2993	26	6	north america.10	LOC
fnp-2993	26	7	0.84-1.12	MONEY
fnp-2993	26	8	10	CARDINAL
fnp-2993	26	9	hiv)12	CARDINAL
fnp-2993	28	1	1	CARDINAL
fnp-2993	28	2	2	CARDINAL
fnp-2993	29	1	four	CARDINAL
fnp-2993	30	1	3.	CARDINAL
fnp-2993	30	2	2	CARDINAL
fnp-2993	30	3	2 and	PERCENT
fnp-2993	30	4	4	CARDINAL
fnp-2993	30	5	nrp1	GPE
fnp-2993	31	1	4	CARDINAL
fnp-2993	31	2	covid-19	ORG
fnp-2993	32	1	covid-19	GPE
fnp-2993	33	1	covid-19	ORG
fnp-2993	33	2	6.25	CARDINAL
fnp-2993	33	3	83.3%	PERCENT
fnp-2993	33	4	covid-19 rt-pcr testing	PERSON
fnp-2993	34	1	covid-19 rt-pcr positivity	PERSON
fnp-2993	34	2	5.1 ±	PERCENT
fnp-2993	34	3	1.5 days	DATE
fnp-2993	34	4	reported.33	ORG
fnp-2993	34	5	covid-19 days	DATE
fnp-2993	34	6	rt-pcr positivity	ORG
fnp-2993	35	1	two	CARDINAL
fnp-2993	36	1	covid-19	PRODUCT
fnp-2993	36	2	first	ORDINAL
fnp-2993	37	1	covid-19	PERSON
fnp-2993	37	2	covid-19	ORG
fnp-2993	37	3	2	CARDINAL
fnp-2993	38	1	2	CARDINAL
fnp-2993	38	2	covid-19	ORG
fnp-2993	39	1	gbs=	ORG
fnp-2993	39	2	guillain-barré	PERSON
fnp-2993	40	1	6	CARDINAL
fnp-2993	40	2	covid-19	PRODUCT
fnp-2993	40	3	covid-19	ORG
fnp-2993	40	4	dysgeusia	PERSON
fnp-2993	40	5	guillain-barré	PERSON
fnp-2993	40	6	meningoencephalitis	ORG
fnp-2993	42	1	chinese	NORP
fnp-2993	42	2	36.4%	PERCENT
fnp-2993	42	3	214	CARDINAL
fnp-2993	42	4	covid-19	PRODUCT
fnp-2993	42	5	16.8%	PERCENT
fnp-2993	42	6	13.1%	PERCENT
fnp-2993	42	7	7.5%	PERCENT
fnp-2993	42	8	dysgeusia	PERSON
fnp-2993	42	9	5.6%	PERCENT
fnp-2993	42	10	5.1%).44	CARDINAL
fnp-2993	42	11	dysgeusia	PERSON
fnp-2993	42	12	french	NORP
fnp-2993	42	13	49	CARDINAL
fnp-2993	42	14	58	DATE
fnp-2993	42	15	84%	PERCENT
fnp-2993	43	1	covid-19	DATE
fnp-2993	43	2	69%	PERCENT
fnp-2993	43	3	65%	PERCENT
fnp-2993	43	4	67%	PERCENT
fnp-2993	43	5	british	NORP
fnp-2993	43	6	7	CARDINAL
fnp-2993	43	7	covid-19	ORG
fnp-2993	43	8	china	GPE
fnp-2993	43	9	covid-19	GPE
fnp-2993	43	10	less than 6%	PERCENT
fnp-2993	43	11	european	NORP
fnp-2993	43	12	88.8%	PERCENT
fnp-2993	43	13	385	CARDINAL
fnp-2993	43	14	covid-19	PRODUCT
fnp-2993	43	15	85.6%	PERCENT
fnp-2993	43	16	417	CARDINAL
fnp-2993	43	17	covid-19	PRODUCT
fnp-2993	43	18	california	GPE
fnp-2993	43	19	71%	PERCENT
fnp-2993	43	20	59	CARDINAL
fnp-2993	43	21	covid-19	PRODUCT
fnp-2993	43	22	68%	PERCENT
fnp-2993	43	23	anosmia.46	GPE
fnp-2993	43	24	covid-19	DATE
fnp-2993	43	25	17 to 30 days	DATE
fnp-2993	43	26	one	CARDINAL
fnp-2993	43	27	day 30	DATE
fnp-2993	43	28	covid-19	PRODUCT
fnp-2993	43	29	87%	PERCENT
fnp-2993	43	30	82%	PERCENT
fnp-2993	44	1	covid-19	ORG
fnp-2993	45	1	two	CARDINAL
fnp-2993	45	2	new york	GPE
fnp-2993	45	3	1.6%	PERCENT
fnp-2993	45	4	1,916	CARDINAL
fnp-2993	45	5	covid-19	ORG
fnp-2993	45	6	0.9%	PERCENT
fnp-2993	45	7	3,556	CARDINAL
fnp-2993	45	8	covid-19	PRODUCT
fnp-2993	45	9	covid-19	PRODUCT
fnp-2993	45	10	third	ORDINAL
fnp-2993	45	11	new york	GPE
fnp-2993	45	12	1.1%	PERCENT
fnp-2993	45	13	3,218	CARDINAL
fnp-2993	45	14	covid-19	PRODUCT
fnp-2993	45	15	68.5%	PERCENT
fnp-2993	45	16	44.5%	PERCENT
fnp-2993	45	17	24%	PERCENT
fnp-2993	45	18	24%	PERCENT
fnp-2993	45	19	chinese	NORP
fnp-2993	45	20	214	CARDINAL
fnp-2993	45	21	covid-19	PRODUCT
fnp-2993	45	22	six	CARDINAL
fnp-2993	45	23	2.8%).44	CARDINAL
fnp-2993	45	24	american	NORP
fnp-2993	45	25	five	CARDINAL
fnp-2993	45	26	covid-19	PRODUCT
fnp-2993	45	27	younger than 50	CARDINAL
fnp-2993	45	28	four	CARDINAL
fnp-2993	45	29	stroke.58	EVENT
fnp-2993	45	30	u.s.	GPE
fnp-2993	45	31	approximately 3.2%.59	CARDINAL
fnp-2993	45	32	only 0.2%	PERCENT
fnp-2993	45	33	1486	CARDINAL
fnp-2993	45	34	new york	GPE
fnp-2993	45	35	33	CARDINAL
fnp-2993	45	36	755	CARDINAL
fnp-2993	45	37	4.4%	PERCENT
fnp-2993	46	1	covid-19	DATE
fnp-2993	46	2	five	CARDINAL
fnp-2993	46	3	seven	CARDINAL
fnp-2993	46	4	17	CARDINAL
fnp-2993	46	5	four.60 twenty-six	DATE
fnp-2993	46	6	33	CARDINAL
fnp-2993	46	7	five	CARDINAL
fnp-2993	46	8	four	CARDINAL
fnp-2993	46	9	the 72 hours	TIME
fnp-2993	46	10	covid-19	PERSON
fnp-2993	46	11	canadian	NORP
fnp-2993	46	12	covid-19	PRODUCT
fnp-2993	46	13	american	NORP
fnp-2993	46	14	covid-19	ORG
fnp-2993	46	15	death.69	ORG
fnp-2993	46	16	covid-19	ORG
fnp-2993	46	17	covid-19	PERSON
fnp-2993	47	1	guillain-barré	PERSON
fnp-2993	48	1	covid-19	GPE
fnp-2993	48	2	paresthesia.70–72 rt-pcr	PERSON
fnp-2993	48	3	csf	PERSON
fnp-2993	48	4	patients.73–75	NORP
fnp-2993	48	5	between day five to 10	DATE
fnp-2993	48	6	covid-19 symptom onset.71 over 30	PERSON
fnp-2993	48	7	reported.73–76	NORP
fnp-2993	49	1	covid-19	PERSON
fnp-2993	49	2	fisher	PERSON
fnp-2993	49	3	areflexia	PERSON
fnp-2993	49	4	cranialis	PERSON
fnp-2993	49	5	covid-19	PERSON
fnp-2993	49	6	one	CARDINAL
fnp-2993	49	7	suspected.33	GPE
fnp-2993	49	8	24-year-old	DATE
fnp-2993	49	9	japanese	NORP
fnp-2993	50	1	nine days	DATE
fnp-2993	50	2	covid-19	DATE
fnp-2993	52	1	covid-19	ORG
fnp-2993	52	2	meningoencephalitis	ORG
fnp-2993	52	3	section 8.79	LAW
fnp-2993	52	4	three	CARDINAL
fnp-2993	52	5	covid-19	PRODUCT
fnp-2993	52	6	younger than	DATE
fnp-2993	52	7	41 years	DATE
fnp-2993	52	8	covid-19	GPE
fnp-2993	52	9	covid-19	ORG
fnp-2993	52	10	storms.81 covid-19	PERSON
fnp-2993	52	11	8	CARDINAL
fnp-2993	53	1	covid-19	PERSON
fnp-2993	53	2	covid-19	DATE
fnp-2993	53	3	20	CARDINAL
fnp-2993	53	4	184	CARDINAL
fnp-2993	53	5	101	CARDINAL
fnp-2993	53	6	83	CARDINAL
fnp-2993	53	7	ihc	ORG
fnp-2993	53	8	four	CARDINAL
fnp-2993	53	9	one	CARDINAL
fnp-2993	55	1	1	CARDINAL
fnp-2993	55	2	3a	CARDINAL
fnp-2993	55	3	3b	CARDINAL
fnp-2993	55	4	microthrombi	GPE
fnp-2993	57	1	1	CARDINAL
fnp-2993	57	2	covid-19	ORG
fnp-2993	57	3	1	CARDINAL
fnp-2993	60	1	3	CARDINAL
fnp-2993	60	2	covid-19 histopathology	PERSON
fnp-2993	60	3	400x	PRODUCT
fnp-2993	60	4	purkinje	GPE
fnp-2993	60	5	200x	CARDINAL
fnp-2993	60	6	100x	CARDINAL
fnp-2993	60	7	d.	NORP
fnp-2993	60	8	400x	CARDINAL
fnp-2993	61	1	at least three	CARDINAL
fnp-2993	61	2	covid-19	GPE
fnp-2993	62	1	covid-19	PRODUCT
fnp-2993	62	2	one	CARDINAL
fnp-2993	62	3	ace2	PERSON
fnp-2993	63	1	ihc	ORG
fnp-2993	63	2	covid-19	PRODUCT
fnp-2993	63	3	second	ORDINAL
fnp-2993	65	1	third	ORDINAL
fnp-2993	65	2	cells.110 histologically	ORG
fnp-2993	66	1	ihc	ORG
fnp-2993	67	1	as many as 54	CARDINAL
fnp-2993	67	2	101	CARDINAL
fnp-2993	67	3	53.5%	PERCENT
fnp-2993	67	4	23	CARDINAL
fnp-2993	67	5	83	DATE
fnp-2993	67	6	27.7%	PERCENT
fnp-2993	67	7	ihc	ORG
fnp-2993	67	8	1	CARDINAL
fnp-2993	69	1	ihc	ORG
fnp-2993	74	1	one	CARDINAL
fnp-2993	74	2	meinhardt	PERSON
fnp-2993	74	3	mucus.53	NORP
fnp-2993	75	1	ihc	ORG
fnp-2993	78	1	months	DATE
fnp-2993	79	1	covid-19	DATE
fnp-2993	79	2	ihc	ORG
fnp-2993	79	3	asia	LOC
fnp-2993	79	4	the united states	GPE
fnp-2993	82	1	covid-19	GPE
fnp-2993	82	2	non-covid-19	PRODUCT
fnp-2993	82	3	covid-19	PERSON
fnp-2993	82	4	meningoencephalitis	ORG
fnp-2993	83	1	matschke	GPE
fnp-2993	83	2	four	CARDINAL
fnp-2993	83	3	16	CARDINAL
fnp-2993	83	4	10	CARDINAL
fnp-2993	83	5	at least three	CARDINAL
fnp-2993	84	1	three	CARDINAL
fnp-2993	84	2	four	CARDINAL
fnp-2993	84	3	three	CARDINAL
fnp-2993	84	4	six	CARDINAL
fnp-2993	84	5	five	CARDINAL
fnp-2993	84	6	six	CARDINAL
fnp-2993	84	7	affected.53	NORP
fnp-2993	84	8	covid-19	PRODUCT
fnp-2993	84	9	rt-pcr,111–113	PERSON
fnp-2993	84	10	at least four	CARDINAL
fnp-2993	84	11	covid-19	ORG
fnp-2993	84	12	one	CARDINAL
fnp-2993	84	13	covid-19	ORG
fnp-2993	88	1	one	CARDINAL
fnp-2993	88	2	microthrombi	GPE
fnp-2993	88	3	covid-19	ORG
fnp-2993	88	4	ihc	ORG
fnp-2993	89	1	il-1β	PERSON
fnp-2993	89	2	covid-19	DATE
fnp-2993	89	3	approximately 1.6%	PERCENT
fnp-2993	89	4	1	CARDINAL
fnp-2993	91	1	3c	CARDINAL
fnp-2993	91	2	covid-19	PRODUCT
fnp-2993	92	1	one	CARDINAL
fnp-2993	92	2	covid-19	PRODUCT
fnp-2993	92	3	ii astrocytosis	PERSON
fnp-2993	92	4	ii astrocytosis	PERSON
fnp-2993	92	5	3d	CARDINAL
fnp-2993	92	6	five	CARDINAL
fnp-2993	92	7	20	CARDINAL
fnp-2993	92	8	solomon	PERSON
fnp-2993	92	9	four	CARDINAL
fnp-2993	92	10	four	CARDINAL
fnp-2993	93	1	9	CARDINAL
fnp-2993	93	2	covid-19	DATE
fnp-2993	98	1	covid-19	PERSON
fnp-2993	107	1	mh083500	CARDINAL
fnp-2993	107	2	s. magaki	PERSON
fnp-2993	107	3	e. singer	PERSON
fnp-2993	107	4	w. yong	PERSON
fnp-2993	107	5	19	CARDINAL
fnp-2993	107	6	#20-70	MONEY
fnp-2993	107	7	s. magaki	PERSON
fnp-2993	107	8	t. zhang	PERSON
fnp-2993	108	1	1	CARDINAL
fnp-2993	108	2	covid-19	ORG
fnp-2993	110	1	october 21, 2020	DATE
fnp-2993	111	1	2	CARDINAL
fnp-2993	111	2	weekly	DATE
fnp-2993	111	3	29	CARDINAL
fnp-2993	111	4	december 2020	DATE
fnp-2993	113	1	december 30, 2020	DATE
fnp-2993	114	1	3	CARDINAL
fnp-2993	114	2	yuen ks	PERSON
fnp-2993	114	3	fung sy	PERSON
fnp-2993	114	4	chan cp	PERSON
fnp-2993	114	5	jin dy	PERSON
fnp-2993	116	1	biol sci	PERSON
fnp-2993	117	1	2020;16(10):1686-1697	CARDINAL
fnp-2993	118	1	4	CARDINAL
fnp-2993	118	2	zhu n	PERSON
fnp-2993	118	3	wang w	PERSON
fnp-2993	119	1	china	GPE
fnp-2993	119	2	2019	DATE
fnp-2993	121	1	2020;382(8):727-733	CARDINAL
fnp-2993	122	1	5	CARDINAL
fnp-2993	123	1	caly l	PERSON
fnp-2993	123	2	roberts j	PERSON
fnp-2993	123	3	2019	CARDINAL
fnp-2993	123	4	first	ORDINAL
fnp-2993	123	5	covid-19	ORG
fnp-2993	123	6	australia	GPE
fnp-2993	124	1	j aust	PERSON
fnp-2993	125	1	462	CARDINAL
fnp-2993	127	1	basile k	PERSON
fnp-2993	127	2	chen s	PERSON
fnp-2993	127	3	rawlinson w.	PERSON
fnp-2993	127	4	2	CARDINAL
fnp-2993	128	1	2020;52(7):745-753	CARDINAL
fnp-2993	129	1	doi:10.1016	GPE
fnp-2993	129	2	7	CARDINAL
fnp-2993	129	3	koyama t	PERSON
fnp-2993	129	4	parida l.	PERSON
fnp-2993	130	1	bull world health	ORG
fnp-2993	131	1	2020;98(7):495-504	CARDINAL
fnp-2993	131	2	8	CARDINAL
fnp-2993	131	3	naqvi aat	PERSON
fnp-2993	131	4	fatima k	PERSON
fnp-2993	131	5	mohammad	PERSON
fnp-2993	133	1	acta mol basis dis	ORG
fnp-2993	135	1	doi:10.1016	PERSON
fnp-2993	135	2	9	CARDINAL
fnp-2993	135	3	liu y	PERSON
fnp-2993	135	4	lei x	PERSON
fnp-2993	136	1	nat commun	PERSON
fnp-2993	137	1	2020;11(1	CARDINAL
fnp-2993	138	1	doi:10.1038	ORG
fnp-2993	139	1	pachetti m	PERSON
fnp-2993	139	2	marini	PERSON
fnp-2993	139	3	benedetti	GPE
fnp-2993	142	1	2020;18(1):1	CARDINAL
fnp-2993	143	1	lion s	ORG
fnp-2993	145	1	curr	PERSON
fnp-2993	146	1	2020;30(15):r849	CARDINAL
fnp-2993	146	2	doi:10.1016/j.cub.2020.06.031 12	GPE
fnp-2993	147	1	rowland-jones s	ORG
fnp-2993	147	2	andrews sm	PERSON
fnp-2993	150	1	2017;6(0):1	CARDINAL
fnp-2993	151	1	nobusawa e	PERSON
fnp-2993	151	2	sato k. comparison	PERSON
fnp-2993	152	1	j virol	PERSON
fnp-2993	153	1	2006;80(7):3675-3678	DATE
fnp-2993	155	1	gheblawi m	PERSON
fnp-2993	155	2	wang k	PERSON
fnp-2993	155	3	2	CARDINAL
fnp-2993	155	4	20th	ORDINAL
fnp-2993	157	1	2020;126(10):1456-1474	CARDINAL
fnp-2993	159	1	wang k	PERSON
fnp-2993	159	2	chen w	PERSON
fnp-2993	159	3	zhang z	PERSON
fnp-2993	162	1	2020;5(1):283	CARDINAL
fnp-2993	162	2	doi:10.1038	ORG
fnp-2993	162	3	16	CARDINAL
fnp-2993	166	1	2017;8(1	CARDINAL
fnp-2993	167	1	017	CARDINAL
fnp-2993	168	1	hu y	PERSON
fnp-2993	168	2	li x	PERSON
fnp-2993	168	3	wu n	PERSON
fnp-2993	168	4	wang n	PERSON
fnp-2993	168	5	li j. study	PERSON
fnp-2993	170	1	2018;39(8):884-887	CARDINAL
fnp-2993	171	1	liu y	PERSON
fnp-2993	171	2	zhao l	PERSON
fnp-2993	171	3	zhang q, zhang l	PERSON
fnp-2993	171	4	ren g.	PERSON
fnp-2993	173	1	2019;40(4):258-260	CARDINAL
fnp-2993	173	2	smith jc	PERSON
fnp-2993	173	3	girish	NORP
fnp-2993	173	4	ace2	PERSON
fnp-2993	175	1	2020;53(5):514-529.e3	CARDINAL
fnp-2993	177	1	bernardi s	PERSON
fnp-2993	179	1	2012;27(5):1793-1800	DATE
fnp-2993	181	1	lavrentyev en	PERSON
fnp-2993	181	2	malik ku	PERSON
fnp-2993	182	1	j physiol	PERSON
fnp-2993	183	1	2009;296(1):106-118	CARDINAL
fnp-2993	183	2	22	CARDINAL
fnp-2993	184	1	xia h	PERSON
fnp-2993	184	2	e. angiotensin-converting	PERSON
fnp-2993	184	3	2	CARDINAL
fnp-2993	186	1	2008;107(6):1482-1494	CARDINAL
fnp-2993	187	1	doi:10.1111	ORG
fnp-2993	189	1	covid-19	ORG
fnp-2993	190	1	sci adv	PERSON
fnp-2993	191	1	2020;6(31):eabc5801	PERSON
fnp-2993	191	2	24	CARDINAL
fnp-2993	192	1	chen m	PERSON
fnp-2993	192	2	shen w	PERSON
fnp-2993	192	3	rowan nr	PERSON
fnp-2993	193	1	j. 2020;56(3):2001948	PERSON
fnp-2993	194	1	doi:10.1183/13993003.01948-2020 25	DATE
fnp-2993	195	1	matschke j	PERSON
fnp-2993	195	2	covid-19	GPE
fnp-2993	195	3	germany	GPE
fnp-2993	196	1	lancet neurol	PERSON
fnp-2993	197	1	2020;19(11	CARDINAL
fnp-2993	198	1	doi:10.1016	PERSON
fnp-2993	199	1	wang k	PERSON
fnp-2993	199	2	chen w	PERSON
fnp-2993	199	3	zhou y sen	PERSON
fnp-2993	201	1	biorxiv	ORG
fnp-2993	202	1	january 1	DATE
fnp-2993	202	2	doi:10.1101/2020.03.14.988345 27	FAC
fnp-2993	203	1	cantuti-castelvetri l	ORG
fnp-2993	203	2	ojha	GPE
fnp-2993	203	3	pedro ld	PERSON
fnp-2993	205	1	biorxiv	ORG
fnp-2993	206	1	january 1	DATE
fnp-2993	206	2	28	CARDINAL
fnp-2993	207	1	hoffmann m	PERSON
fnp-2993	207	2	kleine-weber h	ORG
fnp-2993	207	3	schroeder s	ORG
fnp-2993	210	1	2020;181(2):271	CARDINAL
fnp-2993	211	1	doi:10.1016/j.cell.2020.02.052 29	ORG
fnp-2993	212	1	zang	PERSON
fnp-2993	212	2	gomez castro	PERSON
fnp-2993	212	3	mccune	PERSON
fnp-2993	213	1	tmprss4	ORG
fnp-2993	214	1	sci immunol	PERSON
fnp-2993	215	1	2020;5(47):eabc3582	CARDINAL
fnp-2993	215	2	30	CARDINAL
fnp-2993	216	1	covid-19 rt-pcr	PERSON
fnp-2993	216	2	eua	ORG
fnp-2993	217	1	america	GPE
fnp-2993	218	1	september 2, 2020	DATE
fnp-2993	222	1	covid-19	ORG
fnp-2993	224	1	2020;126:108961	CARDINAL
fnp-2993	224	2	doi:10.1016/j.ejrad.2020.108961 32	GPE
fnp-2993	225	1	yang z	PERSON
fnp-2993	225	2	hou h	GPE
fnp-2993	226	1	2019	DATE
fnp-2993	226	2	covid-19	ORG
fnp-2993	226	3	china	GPE
fnp-2993	226	4	1014	CARDINAL
fnp-2993	228	1	2020;296(2):e32	CARDINAL
fnp-2993	229	1	33	CARDINAL
fnp-2993	230	1	moriguchi t	ORG
fnp-2993	231	1	first	ORDINAL
fnp-2993	233	1	2020;94:55	CARDINAL
fnp-2993	234	1	doi:10.1016	GPE
fnp-2993	234	2	34	CARDINAL
fnp-2993	235	1	perera rapm	PERSON
fnp-2993	235	2	tso e	PERSON
fnp-2993	235	3	tsang oty	PERSON
fnp-2993	237	1	2020;26(11):2701	CARDINAL
fnp-2993	237	2	35	CARDINAL
fnp-2993	238	1	dai w-c	ORG
fnp-2993	238	2	zhang hw	PERSON
fnp-2993	238	3	yu j	PERSON
fnp-2993	239	1	covid-19	DATE
fnp-2993	240	1	assoc	GPE
fnp-2993	240	2	j. 2020;71(2):195-200	PERSON
fnp-2993	241	1	36	CARDINAL
fnp-2993	242	1	guo l	PERSON
fnp-2993	242	2	ren l	ORG
fnp-2993	242	3	yang s	PERSON
fnp-2993	242	4	covid-19	ORG
fnp-2993	243	1	clin	PERSON
fnp-2993	244	1	march 2020	DATE
fnp-2993	245	1	37	CARDINAL
fnp-2993	246	1	vincent al	PERSON
fnp-2993	248	1	2020;2123:321-333	CARDINAL
fnp-2993	251	1	nma	ORG
fnp-2993	251	2	müller ma	PERSON
fnp-2993	251	3	li w	PERSON
fnp-2993	252	1	2	CARDINAL
fnp-2993	252	2	2019	CARDINAL
fnp-2993	255	1	39	CARDINAL
fnp-2993	256	1	sun b	PERSON
fnp-2993	256	2	feng y	PERSON
fnp-2993	256	3	mo x	PERSON
fnp-2993	257	1	igg	ORG
fnp-2993	257	2	covid-19	GPE
fnp-2993	259	1	2020;9(1):940	CARDINAL
fnp-2993	260	1	40	DATE
fnp-2993	261	1	krammer f	ORG
fnp-2993	261	2	simon v. serology assays	PERSON
fnp-2993	261	3	covid-19	PRODUCT
fnp-2993	262	1	2020;368(6495):1060-1061	CARDINAL
fnp-2993	263	1	41	CARDINAL
fnp-2993	264	1	wiersinga wj	PERSON
fnp-2993	264	2	cheng ac	PERSON
fnp-2993	264	3	prescott	ORG
fnp-2993	264	4	2019	DATE
fnp-2993	264	5	covid-19	ORG
fnp-2993	266	1	2020;324(8):782-793	CARDINAL
fnp-2993	267	1	doi:10.1001	GPE
fnp-2993	269	1	shi l	PERSON
fnp-2993	269	2	wang y	PERSON
fnp-2993	270	1	covid-19	ORG
fnp-2993	271	1	lancet respir med.	ORG
fnp-2993	272	1	2020;8(4):420	CARDINAL
fnp-2993	272	2	doi:10.1016	NORP
fnp-2993	272	3	43	CARDINAL
fnp-2993	273	1	jose rj	PERSON
fnp-2993	273	2	manuel a. covid-19	PERSON
fnp-2993	274	1	lancet respir med.	PERSON
fnp-2993	276	1	doi:10.1016	GPE
fnp-2993	277	1	wang m	PERSON
fnp-2993	277	2	2019	DATE
fnp-2993	277	3	wuhan	GPE
fnp-2993	277	4	china	GPE
fnp-2993	278	1	jama neurol	PERSON
fnp-2993	279	1	2020;77(6):683-690	DATE
fnp-2993	280	1	doi:10.1001	GPE
fnp-2993	280	2	45	CARDINAL
fnp-2993	281	1	lechien jr	PERSON
fnp-2993	281	2	covid-19	ORG
fnp-2993	281	3	european	NORP
fnp-2993	283	1	2020;277(8):2251	CARDINAL
fnp-2993	285	1	yan ch	PERSON
fnp-2993	285	2	prajapati	PERSON
fnp-2993	285	3	boone ce	ORG
fnp-2993	285	4	covid-19	ORG
fnp-2993	286	1	rhinol	GPE
fnp-2993	287	1	2020;10(7):806-813	CARDINAL
fnp-2993	288	1	47	CARDINAL
fnp-2993	289	1	helms j	PERSON
fnp-2993	289	2	kremer	PERSON
fnp-2993	289	3	merdji h	ORG
fnp-2993	292	1	2020;382(21):2268	CARDINAL
fnp-2993	294	1	paterson rw	PERSON
fnp-2993	294	2	brown rl	PERSON
fnp-2993	294	3	benjamin l	PERSON
fnp-2993	295	1	covid-19	ORG
fnp-2993	297	1	2020;143(10):3104-3120	DATE
fnp-2993	299	1	paolo g.	PERSON
fnp-2993	299	2	covid-19	ORG
fnp-2993	301	1	doi:10.1016	GPE
fnp-2993	301	2	50	CARDINAL
fnp-2993	302	1	whitehead e	PERSON
fnp-2993	302	2	kumar bn	PERSON
fnp-2993	303	1	covid-19	PRODUCT
fnp-2993	305	1	2020;49(1):26	CARDINAL
fnp-2993	305	2	whitcroft kl	PERSON
fnp-2993	305	3	hummel t. olfactory	PERSON
fnp-2993	305	4	covid-19	DATE
fnp-2993	307	1	2020;323(24):2512-2514	CARDINAL
fnp-2993	308	1	doi:10.1001	GPE
fnp-2993	308	2	52	CARDINAL
fnp-2993	309	1	mattavelli	GPE
fnp-2993	310	1	covid-19	PERSON
fnp-2993	312	1	2020;163(6):1144-1149	CARDINAL
fnp-2993	313	1	53	CARDINAL
fnp-2993	314	1	meinhardt j	PERSON
fnp-2993	314	2	radke j	PERSON
fnp-2993	314	3	covid-19	ORG
fnp-2993	315	1	nat neurosci	PERSON
fnp-2993	315	2	2020	DATE
fnp-2993	316	1	doi:10.1038	ORG
fnp-2993	317	1	morbini p	PERSON
fnp-2993	317	2	benazzo m	ORG
fnp-2993	320	1	2020;146(10):972-973	CARDINAL
fnp-2993	321	1	doi:10.1001	GPE
fnp-2993	322	1	merkler ae	PERSON
fnp-2993	322	2	parikh ns	PERSON
fnp-2993	322	3	mir s	PERSON
fnp-2993	322	4	2019	DATE
fnp-2993	322	5	covid-19	ORG
fnp-2993	323	1	jama neurol	PERSON
fnp-2993	324	1	2020;77(11):1–7	CARDINAL
fnp-2993	325	1	doi:10.1001	GPE
fnp-2993	325	2	56	CARDINAL
fnp-2993	326	1	yaghi s	PERSON
fnp-2993	326	2	ishida k	PERSON
fnp-2993	327	1	new york	GPE
fnp-2993	329	1	2020;51(7):2002-2011	DATE
fnp-2993	330	1	57	CARDINAL
fnp-2993	331	1	jain	PERSON
fnp-2993	331	2	dogra s	PERSON
fnp-2993	332	1	covid-19	PERSON
fnp-2993	333	1	j neurol sci.	PERSON
fnp-2993	334	1	doi:10.1016	GPE
fnp-2993	334	2	58	CARDINAL
fnp-2993	335	1	oxley tj	PERSON
fnp-2993	336	1	covid-19	PRODUCT
fnp-2993	338	1	2020;382(20):e60	CARDINAL
fnp-2993	338	2	59	CARDINAL
fnp-2993	339	1	national hospital ambulatory medical	ORG
fnp-2993	339	2	2017	CARDINAL
fnp-2993	341	1	january 10, 2021	DATE
fnp-2993	342	1	60	CARDINAL
fnp-2993	343	1	dogra s	PERSON
fnp-2993	343	2	covid-19	GPE
fnp-2993	345	1	2020;29(8):104984	PERSON
fnp-2993	347	1	wu z	PERSON
fnp-2993	347	2	mcgoogan jm	PERSON
fnp-2993	347	3	2019	DATE
fnp-2993	347	4	covid-19	ORG
fnp-2993	347	5	china	GPE
fnp-2993	347	6	72	CARDINAL
fnp-2993	347	7	314	CARDINAL
fnp-2993	347	8	chinese	NORP
fnp-2993	349	1	february 2020	DATE
fnp-2993	350	1	doi:10.1001	GPE
fnp-2993	350	2	62	CARDINAL
fnp-2993	351	1	yang j	PERSON
fnp-2993	351	2	zheng y	PERSON
fnp-2993	351	3	gou x	PERSON
fnp-2993	354	1	2020;94:91-95	CARDINAL
fnp-2993	356	1	chen t	PERSON
fnp-2993	356	2	chen h	PERSON
fnp-2993	357	1	113	CARDINAL
fnp-2993	357	2	2019	CARDINAL
fnp-2993	359	1	2020;368	CARDINAL
fnp-2993	359	2	64	DATE
fnp-2993	360	1	jordan	PERSON
fnp-2993	360	2	adab p	ORG
fnp-2993	360	3	cheng kk	PERSON
fnp-2993	361	1	covid-19	PERSON
fnp-2993	362	1	2020;368	CARDINAL
fnp-2993	362	2	bmj.m1198 65	DATE
fnp-2993	363	1	wang b	PERSON
fnp-2993	363	2	li	PERSON
fnp-2993	363	3	huang y.	PERSON
fnp-2993	363	4	covid-19	PERSON
fnp-2993	364	1	ny	GPE
fnp-2993	365	1	2020;12(7):6049-6057	DATE
fnp-2993	366	1	66	CARDINAL
fnp-2993	370	1	2020;28(7):1195-1199	CARDINAL
fnp-2993	372	1	phillips m	PERSON
fnp-2993	372	2	hochman s	PERSON
fnp-2993	372	3	younger than	DATE
fnp-2993	372	4	60 years	DATE
fnp-2993	372	5	covid-19	ORG
fnp-2993	373	1	clin infect dis	ORG
fnp-2993	373	2	april 2020	DATE
fnp-2993	374	1	68	CARDINAL
fnp-2993	375	1	fergusson na	PERSON
fnp-2993	375	2	mitra ar	PERSON
fnp-2993	376	1	multiorgan	GPE
fnp-2993	376	2	covid-19	DATE
fnp-2993	378	1	2020;4(20):4981-4989	DATE
fnp-2993	379	1	69	CARDINAL
fnp-2993	380	1	covid-19	PERSON
fnp-2993	381	1	ann hematol	PERSON
fnp-2993	382	1	2020;99(9):2113-2118	CARDINAL
fnp-2993	384	1	padroni m	PERSON
fnp-2993	384	2	mastrangelo	PERSON
fnp-2993	384	3	gm	ORG
fnp-2993	384	4	guillain-barré	PERSON
fnp-2993	384	5	covid-19	ORG
fnp-2993	385	1	j neurol	PERSON
fnp-2993	386	1	2020;(table	CARDINAL
fnp-2993	387	1	guillain	PERSON
fnp-2993	389	1	2020;382(26):2574	CARDINAL
fnp-2993	389	2	72	CARDINAL
fnp-2993	390	1	dalakas mc	PERSON
fnp-2993	390	2	guillain-barré	PERSON
fnp-2993	390	3	first	ORDINAL
fnp-2993	390	4	covid-19	PERSON
fnp-2993	391	1	neurol neuroimmunol neuroinflammation	PERSON
fnp-2993	392	1	2020;7(5):e781	CARDINAL
fnp-2993	393	1	73	CARDINAL
fnp-2993	394	1	castoro rj	PERSON
fnp-2993	394	2	simmons	PERSON
fnp-2993	395	1	covid-19	CARDINAL
fnp-2993	395	2	guillain-barré	PERSON
fnp-2993	397	1	2020;62(4):485-491	CARDINAL
fnp-2993	398	1	mus.27024 74	DATE
fnp-2993	399	1	trujillo gittermann	PERSON
fnp-2993	399	2	valenzuela feris sn	PERSON
fnp-2993	399	3	von oetinger giacoman a. relation	PERSON
fnp-2993	399	4	covid-19	ORG
fnp-2993	399	5	guillain-barré	PERSON
fnp-2993	400	1	covid-19	DATE
fnp-2993	400	2	y síndrome de guillain-barré en adultos	PERSON
fnp-2993	401	1	revisión sistemática	PERSON
fnp-2993	402	1	neurologia	PERSON
fnp-2993	403	1	2020;35(9):646-654	CARDINAL
fnp-2993	405	1	abu-rumeileh s	PERSON
fnp-2993	405	2	foschi m	ORG
fnp-2993	405	3	tumani h	ORG
fnp-2993	405	4	otto m. guillain-barré	PERSON
fnp-2993	405	5	covid-19	PERSON
fnp-2993	405	6	73	CARDINAL
fnp-2993	406	1	j neurol	PERSON
fnp-2993	407	1	august 25	DATE
fnp-2993	407	2	2020:1	CARDINAL
fnp-2993	409	1	76	CARDINAL
fnp-2993	410	1	k. guillain-barre	PERSON
fnp-2993	410	2	covid-19	PRODUCT
fnp-2993	411	1	neurol sci	PERSON
fnp-2993	412	1	2020;41(11):3149-3156	CARDINAL
fnp-2993	413	1	020	CARDINAL
fnp-2993	414	1	ehrenfeld m	ORG
fnp-2993	414	2	covid-19	PERSON
fnp-2993	415	1	autoimmun rev	PERSON
fnp-2993	416	1	2020;19(8):102597	PERSON
fnp-2993	416	2	doi:10.1016	NORP
fnp-2993	416	3	78	CARDINAL
fnp-2993	417	1	gutiérrez-ortiz	PERSON
fnp-2993	417	2	rodrigo-rey s	ORG
fnp-2993	418	1	fisher	PERSON
fnp-2993	418	2	covid-19	DATE
fnp-2993	419	1	2020;241:10.1212	CARDINAL
fnp-2993	420	1	doi:10.1212	PERSON
fnp-2993	420	2	wnl.0000000000009619 79	ORG
fnp-2993	421	1	von weyhern ch,	PERSON
fnp-2993	421	2	neff f	PERSON
fnp-2993	421	3	kremer m. early	PERSON
fnp-2993	421	4	covid-19	ORG
fnp-2993	422	1	lancet	ORG
fnp-2993	422	2	london	GPE
fnp-2993	422	3	england	GPE
fnp-2993	423	1	2020;395(10241):e109	CARDINAL
fnp-2993	424	1	doi:10.1016	PERSON
fnp-2993	425	1	raz e	PERSON
fnp-2993	425	2	shapiro m	PERSON
fnp-2993	425	3	covid-19	ORG
fnp-2993	425	4	j neuroradiol	PERSON
fnp-2993	426	1	2020;41(8):1-7	DATE
fnp-2993	426	2	81	CARDINAL
fnp-2993	427	1	poyiadji n	PERSON
fnp-2993	427	2	shahin g	PERSON
fnp-2993	427	3	noujaim	GPE
fnp-2993	427	4	griffith b. covid-19	PERSON
fnp-2993	429	1	2020;296(2):e119	CARDINAL
fnp-2993	430	1	82	CARDINAL
fnp-2993	431	1	dixon l	PERSON
fnp-2993	431	2	varley j	PERSON
fnp-2993	433	1	neurol neuroimmunol neuroinflammation	PERSON
fnp-2993	435	1	83	CARDINAL
fnp-2993	436	1	reichard rr	PERSON
fnp-2993	436	2	kashani kb	PERSON
fnp-2993	436	3	boire na	GPE
fnp-2993	436	4	constantopoulos e	PERSON
fnp-2993	436	5	guo y	PERSON
fnp-2993	437	1	covid-19	ORG
fnp-2993	439	1	2020;140(1):1-6	CARDINAL
fnp-2993	440	1	jensen mp	PERSON
fnp-2993	440	2	two	CARDINAL
fnp-2993	440	3	covid-19	PERSON
fnp-2993	442	1	doi:10.1111	ORG
fnp-2993	443	1	covid-19	GPE
fnp-2993	444	1	acta neuropathol	PERSON
fnp-2993	445	1	2020;140(3):397-400	CARDINAL
fnp-2993	447	1	covid-19	DATE
fnp-2993	448	1	acta neuropathol	PERSON
fnp-2993	449	1	2020;140(4):583-586	CARDINAL
fnp-2993	449	2	87	CARDINAL
fnp-2993	450	1	song e	PERSON
fnp-2993	450	2	zhang c	PERSON
fnp-2993	451	1	biorxiv	ORG
fnp-2993	452	1	september 8	DATE
fnp-2993	453	1	doi:10.1101/2020.06.25.169946 88	PERSON
fnp-2993	454	1	roos e	GPE
fnp-2993	454	2	radonic t	GPE
fnp-2993	454	3	covid-19	PERSON
fnp-2993	456	1	2020;1(7):e290	CARDINAL
fnp-2993	456	2	doi:10.1016	PERSON
fnp-2993	456	3	5247(20)30144	CARDINAL
fnp-2993	457	1	thakur kt	PERSON
fnp-2993	457	2	nordvig	ORG
fnp-2993	457	3	neuronophagia	PERSON
fnp-2993	459	1	2020;8(1):147	TIME
fnp-2993	460	1	valencia hs	PERSON
fnp-2993	460	2	barbella-aponte	PERSON
fnp-2993	460	3	covid-19	PERSON
fnp-2993	462	1	2020;143(10):3089	CARDINAL
fnp-2993	463	1	91	CARDINAL
fnp-2993	464	1	fabbri vp	PERSON
fnp-2993	464	2	foschini mp	ORG
fnp-2993	465	1	covid-19	GPE
fnp-2993	465	2	10	CARDINAL
fnp-2993	467	1	october 1, 2020	DATE
fnp-2993	468	1	doi:10.1111	ORG
fnp-2993	468	2	92	CARDINAL
fnp-2993	469	1	troy p	PERSON
fnp-2993	469	2	covid-19	PRODUCT
fnp-2993	471	1	2020;29(11):105231	CARDINAL
fnp-2993	471	2	doi:10.1016/j.jstrokecerebrovasdis.2020.105231 93	ORG
fnp-2993	472	1	patel hn	PERSON
fnp-2993	472	2	syed	PERSON
fnp-2993	473	1	19	CARDINAL
fnp-2993	474	1	interdiscip	PERSON
fnp-2993	474	2	neurosurg adv tech	PERSON
fnp-2993	475	1	2020;22:100850	CARDINAL
fnp-2993	475	2	94	CARDINAL
fnp-2993	476	1	bryce c	PERSON
fnp-2993	476	2	grimes z	PERSON
fnp-2993	477	1	covid-19	PERSON
fnp-2993	479	1	january 1	DATE
fnp-2993	480	1	95	CARDINAL
fnp-2993	482	1	1	CARDINAL
fnp-2993	482	2	covid-19	GPE
fnp-2993	486	1	bryce c	PERSON
fnp-2993	486	2	grimes z	PERSON
fnp-2993	489	1	2020;92(7):699-702	CARDINAL
fnp-2993	489	2	jmv.25915 97	DATE
fnp-2993	490	1	solomon ih	PERSON
fnp-2993	490	2	normandin e	PERSON
fnp-2993	490	3	bhattacharyya s	PERSON
fnp-2993	491	1	covid-19	DATE
fnp-2993	492	1	2020;383(10):989	CARDINAL
fnp-2993	493	1	hanley	ORG
fnp-2993	493	2	naresh kn	PERSON
fnp-2993	494	1	uk	GPE
fnp-2993	494	2	covid-19	PERSON
fnp-2993	496	1	2020;1(6):e245	CARDINAL
fnp-2993	497	1	https://doi.org/10.1016	PERSON
fnp-2993	497	2	5247(20)30115-4 99	PERCENT
fnp-2993	498	1	kantonen j	PERSON
fnp-2993	498	2	mäyränpää mi	PERSON
fnp-2993	498	3	four	CARDINAL
fnp-2993	498	4	covid-19	PRODUCT
fnp-2993	499	1	august 6, 2020	DATE
fnp-2993	500	1	doi:10.1111/bpa.12889	ORG
fnp-2993	500	2	100	CARDINAL
fnp-2993	500	3	zubair	PERSON
fnp-2993	500	4	mcalpine	PERSON
fnp-2993	500	5	gardin	PERSON
fnp-2993	500	6	farhadian s	ORG
fnp-2993	500	7	kuruvilla de	PERSON
fnp-2993	500	8	s. neuropathogenesis	PERSON
fnp-2993	500	9	2019	DATE
fnp-2993	501	1	jama neurol	PERSON
fnp-2993	503	1	doi:10.1001	GPE
fnp-2993	504	1	iadecola c	ORG
fnp-2993	504	2	kamel h.	PERSON
fnp-2993	504	3	covid-19	PRODUCT
fnp-2993	506	1	2020;183(1):16-27.e1	CARDINAL
fnp-2993	506	2	doi:10.1016/j.cell.2020.08.028 102	ORG
fnp-2993	507	1	moore s	PERSON
fnp-2993	507	2	cassell m	PERSON
fnp-2993	507	3	perlman s.	PERSON
fnp-2993	509	1	2008;82(15):7264-7275	DATE
fnp-2993	510	1	08 103	CARDINAL
fnp-2993	511	1	hao xy	PERSON
fnp-2993	511	2	li f di	PERSON
fnp-2993	511	3	xu yf	PERSON
fnp-2993	511	4	gao h.	PERSON
fnp-2993	511	5	hdpp4	PERSON
fnp-2993	513	1	2019;2(4):269-281	CARDINAL
fnp-2993	515	1	politi ls	ORG
fnp-2993	515	2	grimaldi m.	PERSON
fnp-2993	515	3	2019	DATE
fnp-2993	515	4	covid-19	ORG
fnp-2993	516	1	jama neurol	PERSON
fnp-2993	517	1	2020;77(8):1028-1029	CARDINAL
fnp-2993	518	1	doi:10.1001	GPE
fnp-2993	518	2	105	CARDINAL
fnp-2993	519	1	fodoulian l	ORG
fnp-2993	519	2	tuberosa j	PERSON
fnp-2993	522	1	doi:10.1016	GPE
fnp-2993	522	2	106	CARDINAL
fnp-2993	523	1	nampoothiri s	ORG
fnp-2993	523	2	sauve f	ORG
fnp-2993	523	3	ternier g	PERSON
fnp-2993	526	1	january 1	DATE
fnp-2993	528	1	kim wk	PERSON
fnp-2993	528	2	corey s	PERSON
fnp-2993	528	3	alvarez x	PERSON
fnp-2993	528	4	williams k. monocyte	PERSON
fnp-2993	530	1	2003;74(5):650	CARDINAL
fnp-2993	532	1	ulrich c	ORG
fnp-2993	532	2	kohler	ORG
fnp-2993	533	1	2	CARDINAL
fnp-2993	535	1	2017;32(2):287	CARDINAL
fnp-2993	535	2	109	CARDINAL
fnp-2993	536	1	salamanna	PERSON
fnp-2993	537	1	landini mp	PERSON
fnp-2993	537	2	fini m. body localization	PERSON
fnp-2993	539	1	2020;7:935	CARDINAL
fnp-2993	540	1	https://www.frontiersin.org/article/10.3389/fmed.2020.594495 110	ORG
fnp-2993	541	1	bergmann cc	PERSON
fnp-2993	542	1	nat rev microbiol	PERSON
fnp-2993	543	1	2006;4(2):121-132	CARDINAL
fnp-2993	543	2	doi:10.1038/nrmicro1343 111	ORG
fnp-2993	544	1	neumann	ORG
fnp-2993	544	2	dimitriadis k	PERSON
fnp-2993	544	3	covid-19	GPE
fnp-2993	545	1	j neurol sci	PERSON
fnp-2993	546	1	doi:10.1016	GPE
fnp-2993	546	2	112	CARDINAL
fnp-2993	547	1	espíndola	PERSON
fnp-2993	547	2	soares cn	PERSON
fnp-2993	548	1	covid-19	PERSON
fnp-2993	550	1	2020;96:567-569	CARDINAL
fnp-2993	550	2	doi:10.1016	GPE
fnp-2993	550	3	113	CARDINAL
fnp-2993	551	1	schweblin c	PERSON
fnp-2993	551	2	lambeng n	PERSON
fnp-2993	552	1	clin infect dis	ORG
fnp-2993	552	2	august 8, 2020	DATE
fnp-2993	552	3	ciaa1165	PERSON
fnp-2993	553	1	hung ecw	PERSON
fnp-2993	553	2	chim ssc	ORG
fnp-2993	553	3	chan pks	ORG
fnp-2993	554	1	clin chem	ORG
fnp-2993	555	1	2003;49(12):2108-2109	CARDINAL
fnp-2993	557	1	zhou l	PERSON
fnp-2993	557	2	zhang m	PERSON
fnp-2993	557	3	wang j	PERSON
fnp-2993	557	4	gao j. sars-cov-2	PERSON
fnp-2993	559	1	2020;36:101642	CARDINAL
fnp-2993	559	2	doi:10.1016	GPE
fnp-2993	559	3	116	CARDINAL
fnp-2993	560	1	virhammar j	PERSON
fnp-2993	560	2	kumlien e	PERSON
fnp-2993	562	1	2020;95(10):445-449	CARDINAL
fnp-2993	564	1	117	CARDINAL
fnp-2993	565	1	chen g	PERSON
fnp-2993	565	2	wu	PERSON
fnp-2993	565	3	guo w	PERSON
fnp-2993	566	1	2019	DATE
fnp-2993	567	1	j clin	PERSON
fnp-2993	568	1	2020;130(5):2620-2629	CARDINAL
fnp-2993	570	1	huang c	PERSON
fnp-2993	570	2	wang y	PERSON
fnp-2993	570	3	li x	PERSON
fnp-2993	571	1	2019	CARDINAL
fnp-2993	571	2	wuhan	GPE
fnp-2993	571	3	china	GPE
fnp-2993	572	1	lancet	ORG
fnp-2993	573	1	2020;395(10223):497-506	DATE
fnp-2993	573	2	doi:10.1016	PERSON
fnp-2993	574	1	song p	PERSON
fnp-2993	574	2	li w	PERSON
fnp-2993	574	3	xie j	PERSON
fnp-2993	574	4	hou y	PERSON
fnp-2993	575	1	clin chim acta	PERSON
fnp-2993	576	1	2020;509:280	CARDINAL
fnp-2993	577	1	120	CARDINAL
fnp-2993	578	1	goshua g	PERSON
fnp-2993	578	2	meizlish	NORP
fnp-2993	578	3	covid-19	GPE
fnp-2993	579	1	lancet	ORG
fnp-2993	580	1	doi:10.1016	PERSON
fnp-2993	582	1	covid-19	GPE
fnp-2993	583	1	j thromb haemost	PERSON
fnp-2993	584	1	2020;18(5):1023-1026	DATE
fnp-2993	585	1	doi:10.1111	ORG
fnp-2993	586	1	yaqinuddin	PERSON
fnp-2993	586	2	kashir j. covid-19	PERSON
fnp-2993	587	1	respir investig	PERSON
fnp-2993	588	1	2020;58(5):419-420	CARDINAL
fnp-2993	592	1	2019;143(10):1256-1258	CARDINAL
fnp-2993	594	1	0455	DATE
fnp-2993	594	2	2021	CARDINAL
fnp-2993	595	1	4.0	CARDINAL
fnp-2993	595	2	https://creativecommons.org/licenses/by/4.0/	WORK_OF_ART